Literature DB >> 26402426

Role of psychosocial variables on chemotherapy-induced nausea and vomiting and health-related quality of life among cancer patients: a European study.

Luigi Grassi1, Maria Alejandra Berardi, Federica Ruffilli, Elena Meggiolaro, Elisabeth Andritsch, Agustina Sirgo, Rosangela Caruso, Eva Juan Linares, Marta Bellé, Sara Massarenti, Maria Giulia Nanni.   

Abstract

BACKGROUND: Chemotherapy-induced nausea and vomiting (CINV) continue to be a distressing problem still reported by cancer patients, with negative consequences on quality of life (QoL). AIMS: To prospectively explore the association of psychosocial variables, including emotional distress, maladaptive coping styles and the doctor-patient relationship, with CINV and QoL among cancer outpatients.
METHODS: A prospective study was conducted on 302 consecutive cancer patients (response rate 80.9%) in Austria, Italy and Spain. The Distress Thermometer (DT), the Mini-Mental Adjustment to Cancer (Mini-MAC), and the Patient Satisfaction with Doctor Questionnaire (PSQ) were used to assess psychosocial variables before chemotherapy. In the 5 days after chemotherapy, CINV was examined by using a daily diary, and the Functional Living Index for Emesis (FLIE) was used to assess QoL.
RESULTS: More than half of the patients reported nausea (54%), and a small percentage reported vomiting (14%). CINV had a negative impact on QoL (FLIE caseness, p < 0.01). Maladaptive coping (i.e. hopelessness-helplessness and anxious preoccupation) and emotional distress were associated with CINV (p < 0.05) and poorer QoL (p < 0.05). In logistic regression analysis, nausea was predicted by Mini-MAC/H (OR = 1.1, p = 0.03) and younger age (OR = 0.97, p = 0.04); negative impact on QoL was predicted by grade of chemotherapy emetogenesis (OR = 1.7, p < 0.01) and Mini-MAC/H (OR = 1.2, p = 0.04).
CONCLUSIONS: Screening and assessment of psychological variables, especially coping, could help in identifying cancer patients at risk for chemotherapy-induced nausea, in spite of the use of antiemetic treatment.
© 2015 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26402426     DOI: 10.1159/000431256

Source DB:  PubMed          Journal:  Psychother Psychosom        ISSN: 0033-3190            Impact factor:   17.659


  13 in total

Review 1.  Use of Direct Oral Anticoagulants in Patients with Cancer: Practical Considerations for the Management of Patients with Nausea or Vomiting.

Authors:  Hanno Riess; Cihan Ay; Rupert Bauersachs; Cecilia Becattini; Jan Beyer-Westendorf; Francis Cajfinger; Ian Chau; Alexander T Cohen; Alok A Khorana; Anthony Maraveyas; Marcos Renni; Annie M Young
Journal:  Oncologist       Date:  2018-04-12

2.  The incidence of nausea and vomiting in cancer patients in Greek clinical practice: A longitudinal study.

Authors:  Maria Lavdaniti; Nikoletta Margari; Aikaterini Chavela; Michalis Mantzanas; Ioanna Chatzi; Evangelos C Fradelos; Ioannis Tilaveridis; George Tzavelas
Journal:  Contemp Oncol (Pozn)       Date:  2020-06-08

3.  The relationship between physician and cancer patient when initiating adjuvant treatment and its association with sociodemographic and clinical variables.

Authors:  P Jimenez-Fonseca; C Calderon; A Carmona-Bayonas; M M Muñoz; R Hernández; M Mut Lloret; I Ghanem; C Beato; D Cacho Lavín; A Ivars Rubio; R Carrión; C Jara
Journal:  Clin Transl Oncol       Date:  2018-04-02       Impact factor: 3.405

Review 4.  Delayed Chemotherapy-Induced Nausea and Vomiting: Pathogenesis, Incidence, and Current Management.

Authors:  Bernardo L Rapoport
Journal:  Front Pharmacol       Date:  2017-01-30       Impact factor: 5.810

Review 5.  Depressive Spectrum Disorders in Cancer: Diagnostic Issues and Intervention. A Critical Review.

Authors:  Rosangela Caruso; Maria GiuliaNanni; Michelle B Riba; Silvana Sabato; Luigi Grassi
Journal:  Curr Psychiatry Rep       Date:  2017-06       Impact factor: 5.285

Review 6.  Differential pharmacology and clinical utility of rolapitant in chemotherapy-induced nausea and vomiting.

Authors:  Bernardo Leon Rapoport
Journal:  Cancer Manag Res       Date:  2017-02-22       Impact factor: 3.989

7.  Screening Performance of Edmonton Symptom Assessment System in Kidney Transplant Recipients.

Authors:  Yuri Battaglia; Luigi Zerbinati; Giulia Piazza; Elena Martino; Michele Provenzano; Pasquale Esposito; Sara Massarenti; Michele Andreucci; Alda Storari; Luigi Grassi
Journal:  J Clin Med       Date:  2020-04-02       Impact factor: 4.241

Review 8.  Evolving role of neurokinin 1-receptor antagonists for chemotherapy-induced nausea and vomiting.

Authors:  Rudolph M Navari; Lee S Schwartzberg
Journal:  Onco Targets Ther       Date:  2018-10-04       Impact factor: 4.147

9.  Biopsychosocial Correlates of Adjustment to Cancer during Chemotherapy: The Key Role of Health-Related Quality of Life.

Authors:  Marco Lauriola; Manuela Tomai
Journal:  ScientificWorldJournal       Date:  2019-03-10

10.  Post-traumatic stress symptoms in long-term disease-free cancer survivors and their family caregivers.

Authors:  Silvia De Padova; Luigi Grassi; Alessandro Vagheggini; Martino Belvederi Murri; Federica Folesani; Lorena Rossi; Alberto Farolfi; Tatiana Bertelli; Alessandro Passardi; Alejandra Berardi; Ugo De Giorgi
Journal:  Cancer Med       Date:  2021-06-01       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.